SIGLEC1 and COVID-19: In line with the literature that CD169/SIGLEC1 expression is not specific for COVID-19, three out of 27 COVID-19 screening patients tested negative for SARS-CoV-2 showed CD169/SIGLEC1 expression levels above the normal range.